Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$389.71
-$6.72(-1.73%)
At close: 4:00 PM EDT
$389.71
-$6.72(-1.73%)
Day’s Range― - ―
52-Week Range$163.11 - $456.50
Previous CloseN/A
Volume391.94K
Average Volume (3M)1.35M
Market Cap
$49.61B
Enterprise Value$62.43B
Total Cash (Recent Filing)$23.87B
Total Debt (Recent Filing)$14.25B
Price to Earnings (P/E)38.8
Beta1.03
Next Earnings
Nov 06, 2026Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)10.65
Shares Outstanding120,080,310
10 Day Avg. Volume2,015,939
30 Day Avg. Volume1,346,592
Financial Highlights & Ratios
PEG Ratio-18.55
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit3.14
Enterprise Value/Ebitda20.15
Forecast
1Y Price Target
$458.86Price Target Upside17.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
EPS Forecast (FY)9.16
Revenue Forecast (FY)$162.52B
Bulls Say, Bears Say
Bulls Say
CenterWell Capital FlexibilityThe new joint venture provides additional growth capital for CenterWell while keeping Humana responsible for clinic operations. Removing prior put arrangements should reduce balance-sheet liabilities and lower funding costs, improving financial flexibility for expansion and strategic investment.
Improved Medicare Advantage StarsHigher Star Ratings strengthen Humana’s Medicare Advantage competitiveness and can support improved bonus economics, member retention, and enrollment quality. The increase in highly rated contracts and stronger preventive-care engagement also reinforces Humana’s care-management capabilities over multiple years.
Revenue Growth And Manageable LeverageContinued revenue expansion indicates that Humana retains scale and demand across its healthcare businesses, while moderate leverage limits balance-sheet strain. Together, these factors provide a foundation for funding operations and pursuing growth even as profitability recovery remains a priority.
Bears Say
Compressed ProfitabilityThe sharp decline in net and operating margins shows that revenue growth is currently translating into relatively little earnings. Lower profitability reduces internal reinvestment capacity, weakens returns to shareholders, and leaves less cushion against medical-cost or policy pressures.
Elevated Drug-cost TrendPersistent double-digit drug-cost growth can raise claims expense faster than premiums and government payments adjust. Unless pricing, benefit design, rebates, or care management offset the increase, pharmacy pressure could constrain underwriting margins and delay the company’s longer-term profitability goals.
Medicare Plan-exit DisruptionThe planned exits create a substantial membership transition and could reduce scale if displaced members do not move to Humana alternatives. Even with expected recapture, disruption may alter membership mix, increase retention demands, and complicate progress toward margin targets.
HUM FAQ
What was Humana Inc’s price range in the past 12 months?
Humana Inc lowest stock price was $163.11 and its highest was $456.50 in the past 12 months.
What is Humana Inc’s market cap?
Humana Inc’s market cap is $49.61B.
When is Humana Inc’s upcoming earnings report date?
Humana Inc’s upcoming earnings report date is Nov 06, 2026 which is in 18 days.
How were Humana Inc’s earnings last quarter?
Humana Inc released its earnings results on Jul 29, 2026. The company reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.268 by $0.342.
Is Humana Inc overvalued?
According to Wall Street analysts Humana Inc’s price is currently Undervalued.
Does Humana Inc pay dividends?
Humana Inc pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 0.86%. See more information on Humana Inc dividends here
What is Humana Inc’s EPS estimate?
Humana Inc’s EPS estimate is -1.
How many shares outstanding does Humana Inc have?
Humana Inc has 120,080,310 shares outstanding.
What happened to Humana Inc’s price movement after its last earnings report?
Humana Inc reported an EPS of $7.61 in its last earnings report, beating expectations of $7.268. Following the earnings report the stock price went down -5.994%.
Which hedge fund is a major shareholder of Humana Inc?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$458.86 (17.74% Upside)
$458.86 (17.74% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 69%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 553.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.26%
12-Months-Change
Fundamentals
Return on Equity
6.91%
Trailing 12-Months
Asset Growth
13.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Humana Inc
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
HUM Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally constructive operational and strategic progress narrative: clear cost-reduction execution (120 bps Y/Y improvement in Q2 operating cost ratio and expected ~150 bps full-year), tangible improvement in key Stars-related measures (outperforming historical CAGR on most selected metrics and ~5% better quality improvement rate for BY '29 measures), balance-sheet moves (Gentiva divestiture ~ $900M and $1.5B P-Cap facilities) and a new statewide Medicaid win. However, material risks remain — notably elevated and rising drug trend, dependence on membership mix for margin realization, plan-exit disruption (~600k members), elevated reserves/IBNR, and Stars/ policy uncertainty — which temper the outlook. On balance, the highlights (execution, cost savings, Stars operational progress, capital actions) outweigh the lowlights (policy uncertainty, drug trend, membership disruption), producing a cautiously positive sentiment.View all HUM earnings summariesHUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income

HUM Stock 12 Month Forecast
Average Price Target
$458.86
▲(17.74% Upside)
Technical Analysis
Ownership Overview
0.27% Insiders
35.99% Mutual Funds
1.57% Other Institutional Investors
31.01% Public Companies and
Individual Investors











